Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both

Overview of attention for article published in Oncologist, September 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 20 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,983 followers.

Open Access UCL Research: Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both https://t.co/JTusX5qXBl

The JAVELIN Ovarian 200 in pts with PROC Cardiac AEs ≥G3 Ave (2.1%), Ave+PLD (0.5%), and PLD (0%) LVEF decreases ≥10% to below the lower limit Ave (0.8%), Ave+PLD (1.9%), and PLD (1.5%) LVEF in pts With OC Treated With Ave, PLD, or Both https://t.co/X…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.